A Cure for Clinical Burnout?
Australian doctors are facing a significant administrative burden, leading to burnout and less time for patient care. In response, many are turning to a new solution: AI scribes. These tools promise to automate the tedious process of taking clinical notes.
By listening to and transcribing patient consultations, they can generate summaries and letters, freeing up doctors to focus more on their patients rather than their keyboards. The adoption rate has been staggering; a poll from the Royal Australian College of General Practitioners (RACGP) showed that usage among doctors nearly doubled in just over a year, rising from 22% in August 2024 to 40% by November 2025. Proponents argue that this leads to better patient engagement and more detailed documentation, but the rapid uptake has left regulations struggling to catch up.
The Digital Assistant in the Room
So what exactly is an AI scribe? It's sophisticated software that uses artificial intelligence, automatic speech recognition, and natural language processing to listen to, transcribe, and summarise a doctor-patient conversation. Unlike simple dictation software, these tools can structure the conversation into coherent clinical notes. However, this speed and convenience come with a catch. The technology operates in what some experts call the "Wild West of medical technology," with many scribe providers marketing their products as being outside the regulatory scope of the Therapeutic Goods Administration (TGA) because they don't serve a direct therapeutic purpose. This leaves a significant gap in oversight for tools handling some of the most sensitive personal information imaginable.
Who Else is Listening?
The primary concern raised by Australia's federal health department and privacy commissioner is, unsurprisingly, privacy. When an AI scribe is used, where does the audio and transcribed data go? Briefing documents from the health department note that some cloud platforms used by these services may send data outside Australia, where privacy laws might not be as stringent. This raises significant risks for patient data security, including potential breaches. Furthermore, there is a lack of transparency from some providers about how this data is stored, used, or if it's being used to train other AI models. Under Australian law, healthcare practices are ultimately accountable for what happens to their patients' data, even if a breach occurs with an overseas vendor.
Consent, Clarity, and Complications
For the system to work ethically, informed patient consent is crucial. However, reports suggest this is not always happening consistently. The Consumer Health Forum of Australia has heard from patients who were told to find another doctor if they didn't agree to the use of an AI scribe. Beyond consent, there is the critical issue of accuracy. Like all large language models, AI scribes can make mistakes, miss important nuances, or even 'hallucinate'—inventing details that were never said. Studies have found these tools can make factual errors or significant omissions, like missing a patient's smoking history or incorrectly listing medications. The RACGP has warned that GPs are fully liable for any errors in a patient's health record, even if generated by an AI. This places a heavy burden on time-poor doctors to meticulously review every AI-generated note for accuracy.
Regulators Race to Keep Pace
With the technology's use having "little oversight," federal bodies are now scrambling to respond. The Privacy Commissioner's office is closely tracking the rollout and engaging with medical bodies and tech providers. The RACGP has released its own guidelines, emphasising doctor liability, the necessity of explicit consent, and the need for due diligence when selecting a vendor. The core challenge is to strike a balance: harnessing the potential of AI to improve healthcare efficiency and reduce doctor burnout, without sacrificing the fundamental pillars of patient safety, privacy, and trust. Authorities are now considering whether stronger, formal safeguards are required to govern this fast-growing sector of health technology.
